first semaglutide dose GLP-1 Week Dose: What You Need to Know Semaglutide Dosage Chart for Weight

Retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, distinguishing it from currently approved therapies such as semaglutide and tirzepatide

While this is a single case and cannot determine class effects, it is a data point worth noting

Clinical trial data from the STEP 1 study shows that weight loss was observed from the first assessment at week 4, continued steadily through treatment, and reached its lowest point around week 60

In- and exclusion criteria are presented in supplementary Table 1

Their rheumatologists did not note any apparent cause for the recurrent manifestations, and none of these patients required medication changes as a result